Kyungin Synthe (012610.KS) stock: key figures, P/E, revenue and dividend
Materials · Specialty Chemicals · South Korea · ISIN KR7012610002
Kyungin Synthe financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 374.23 bn KRW | 379.70 bn KRW |
| Gross profit | 84.08 bn KRW | 77.72 bn KRW |
| Operating income | 24.23 bn KRW | 18.77 bn KRW |
| EBIT | 27.90 bn KRW | 15.76 bn KRW |
| Net income | 15.33 bn KRW | 5.64 bn KRW |
Full history since 2004, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Kyungin Synthe
Kyungin Synthetic Co., Ltd. develops, manufactures, and sells dyes, inks, fine chemicals, and other materials for use in textiles, food, and electronic products in South Korea. The company offers inks for digital textile printing and UV printing, as well as dyes for inks; reactive dyes, disperse dyes, acid dyes, CDP basic dyes, and optical brightening agents; electronic materials; and fine chemicals, such as saccharin, sulfur, and inorganic products. It also provides organic materials for displays, semiconductor, photoactive compounds, pigments, and functional materials. Kyungin Synthetic Co., Ltd. was founded in 1971 and is headquartered in Seoul, South Korea.
More stocks
- Knaus Tabbert (KTA.DE)
- loanDepot, Inc. (LDI)
- Min Aik Precision Industrial Co Ltd (4545.TW)
- Allmind Holdings Corporation (2718.TWO)
- KTI (0308.KL)
- Kyungdong City Gas Co Ltd (267290.KS)
- Jaeyoung Solutec Co. Ltd (049630.KQ)
- Great Novel Therapeutics Biotech & Medicals (7427.TWO)
- Yen Sun Technology (6275.TWO)
- SERA PROGNOSTICS, INC. (SERA)
- Iljin Diamond (081000.KS)
- Adocia (ADOC.PA)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.